Thomas Jefferson University

Main menu:

Hematologic Cancers Program

Designated a center of excellence in cancer care and research, Thomas Jefferson University Hospitals' Kimmel Cancer Center treats patients with hematological malignancies, the most common forms of which are leukemia (acute and chronic myelogenous and lymphocytic), Hodgkins and non-Hodgkins lymphoma and multiple myeloma. These cancers may arise from the bone marrow, lymph nodes or extra-nodal locations such as the stomach, brain, testes and orbit.

The Kimmel Cancer Center brings together a multidisciplinary team of medical oncologists, radiation oncologists, pathologists and radiologists, who collaborate on evaluation and diagnosis and guide the patient through the most appropriate course of treatment. Chemotherapy is the mainstay of treatment for these cancers, but radiation plays an important role in treating certain types of lymphomas.

The bone marrow transplant team at Jefferson meets the requirements of the Foundation for the Accreditation of Cellular Therapy (FACT) for bone marrow and tissue transplantation. Specialists in the program are pioneering efforts to expand the pool of potential donors and to reduce complications of transplant procedures, such as graft-versus-host disease (GVHD).

Program Physician:
S. Onder Alpdogan, MD
Matthew Carabasi, MD
Joanne Filicko-O'Hara, MD
Neal Flomenberg, MD
Sameh Gaballa, MD
Margaret T. Kasner, MD
Ubaldo Martinez-Outschoorn, MD
Bijoyesh P. Mookerjee, MD
John L. Wagner, MD
Mark Weiss, MD

For further information contact:
Thomas Jefferson University Hospital